Göllner, S., Agrawal-Singh, S., Oellerich, T., Schenk, T., Rohde, C., Klein, H. U., et al. (2016). A novel epigenetic resistance mechanism to the FLT3 inhibitor PK412 induces cross-resistance to standard chemotherapy in acute myeloid leukemia (AML). Haematologica, 101(Suppl. 1), 166-166.